UPDATE: Goldman Sachs Downgrades Biogen (BIIB) to Buy
Tweet Send to a Friend
(Updated - April 25, 2018 4:39 AM EDT)
(updated to add analyst comment)Goldman Sachs downgraded Biogen (NASDAQ: BIIB) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comment)Goldman Sachs downgraded Biogen (NASDAQ: BIIB) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
